| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| R&D Expense | $28.2M | +46.8% |
| SG&A Expense | $10.7M | +12.0% |
| Operating Income | -$39.0M | -35.2% |
| Pre-tax Income | -$38.0M | -32.7% |
| Income Tax | -$60K | +0.0% |
| Net Income | -$38.0M | -32.8% |
| EPS (Basic) | -$3.11 | +23.2% |
| EPS (Diluted) | -$3.11 | +23.2% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $9.6M | -51.9% |
| Current Assets | $10.5M | -49.1% |
| Total Assets | $12.1M | -44.1% |
| Current Liabilities | $12.9M | +134.0% |
| Total Liabilities | $13.4M | +120.8% |
| Stockholders' Equity | -$1.4M | -108.7% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$32.4M | -28.4% |
| Capital Expenditures | $864K | +282.4% |
| Investing Cash Flow | -$864K | -282.4% |
| Financing Cash Flow | $22.9M | +138.7% |
| Free Cash Flow | -$33.2M | -30.6% |